Two biotech stocks make perfect candidates for this sort of strategy right now. Let's take a close look at these two biotech ...

GSK has stopped development of anti-TIGIT antibody belrestotug. | GSK has stopped development of anti-TIGIT antibody ...

By Daniella Parra Jeito Capital said it is leading a €132 million oversubscribed Series B funding round in Azafaros, a ...

Viking Therapeutics has a promising pipeline candidate in the fast-growing therapeutic area of weight loss. Madrigal ...

President Trump could have walked softly and carried a big stick. As pharmaceutical investors see it, he instead stomped ...

Bluebird bio shareholders have dragged their feet in tendering shares as part of the company’s sale process, prompting buyers ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

President Trump announced a plan to reduce prescription drug prices by implementing a most-favored-nation policy with the ...

EDMONTON, Alberta, May 13, 2025 (GLOBE NEWSWIRE) -- Applied Pharmaceutical Innovation (API), one of Canada's leading life sciences commercialization organizations, is proud to announce the appointment ...

Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany ParticipantsBrian Ritchie – LifeSci Advisors LLCHadar Levy ...